Nautilus Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
Nautilus Advisors's AMGN Position: Q2 2026 in Review
Nautilus Advisors reduced its Amgen (AMGN) stake by 2.8% in Q2 2026, selling an estimated $20.2K and leaving 2,048 shares worth $744K. The position accounts for 0.44% of the portfolio, ranked #67.
Nautilus Advisors first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 1,458 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Nautilus Advisors held 2,048 shares of Amgen worth $744K as of Q2 2026.
- Nautilus Advisors sold 59 Amgen shares in Q2 2026, an estimated $20.2K.
- Amgen made up 0.44% of Nautilus Advisors's portfolio in Q2 2026, its #67 holding.
- Nautilus Advisors first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
- 1,458 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Nautilus Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.